196 related articles for article (PubMed ID: 33322317)
1. High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study.
Ling SF; Broad E; Murphy R; Pappachan JM; Pardesi-Newton S; Kong MF; Jude EB
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33322317
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D supplementation and COVID-19 risk: a population-based, cohort study.
Oristrell J; Oliva JC; Casado E; Subirana I; Domínguez D; Toloba A; Balado A; Grau M
J Endocrinol Invest; 2022 Jan; 45(1):167-179. PubMed ID: 34273098
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D supplementation for the treatment of COVID-19: a living systematic review.
Stroehlein JK; Wallqvist J; Iannizzi C; Mikolajewska A; Metzendorf MI; Benstoem C; Meybohm P; Becker M; Skoetz N; Stegemann M; Piechotta V
Cochrane Database Syst Rev; 2021 May; 5(5):CD015043. PubMed ID: 34029377
[TBL] [Abstract][Full Text] [Related]
4. Influence of 25-hydroxy-cholecalciferol levels on SARS-CoV-2 infection and COVID-19 severity: A systematic review and meta-analysis.
Crafa A; Cannarella R; Condorelli RA; Mongioì LM; Barbagallo F; Aversa A; La Vignera S; Calogero AE
EClinicalMedicine; 2021 Jul; 37():100967. PubMed ID: 34179737
[TBL] [Abstract][Full Text] [Related]
5. Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study).
Rastogi A; Bhansali A; Khare N; Suri V; Yaddanapudi N; Sachdeva N; Puri GD; Malhotra P
Postgrad Med J; 2022 Feb; 98(1156):87-90. PubMed ID: 33184146
[TBL] [Abstract][Full Text] [Related]
6. High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): A multicenter, open-label, randomized controlled superiority trial.
Annweiler C; Beaudenon M; Gautier J; Gonsard J; Boucher S; Chapelet G; Darsonval A; Fougère B; Guérin O; Houvet M; Ménager P; Roubaud-Baudron C; Tchalla A; Souberbielle JC; Riou J; Parot-Schinkel E; Célarier T;
PLoS Med; 2022 May; 19(5):e1003999. PubMed ID: 35639792
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of In-Hospital Cholecalciferol Use on Clinical Outcomes in Comorbid COVID-19 Patients: A Hypothesis-Generating Study.
Giannini S; Passeri G; Tripepi G; Sella S; Fusaro M; Arcidiacono G; Torres MO; Michielin A; Prandini T; Baffa V; Aghi A; Egan CG; Brigo M; Zaninotto M; Plebani M; Vettor R; Fioretto P; Rossini M; Vignali A; Fabris F; Bertoldo F
Nutrients; 2021 Jan; 13(1):. PubMed ID: 33466642
[TBL] [Abstract][Full Text] [Related]
8. Calcifediol Treatment and COVID-19-Related Outcomes.
Nogues X; Ovejero D; Pineda-Moncusí M; Bouillon R; Arenas D; Pascual J; Ribes A; Guerri-Fernandez R; Villar-Garcia J; Rial A; Gimenez-Argente C; Cos ML; Rodriguez-Morera J; Campodarve I; Quesada-Gomez JM; Garcia-Giralt N
J Clin Endocrinol Metab; 2021 Sep; 106(10):e4017-e4027. PubMed ID: 34097036
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D and COVID-19 infection and mortality in UK Biobank.
Hastie CE; Pell JP; Sattar N
Eur J Nutr; 2021 Feb; 60(1):545-548. PubMed ID: 32851419
[TBL] [Abstract][Full Text] [Related]
10. Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 Supplementation on Recovery of Symptoms in Patients with Mild to Moderate Covid-19: A Randomized Clinical Trial.
Sabico S; Enani MA; Sheshah E; Aljohani NJ; Aldisi DA; Alotaibi NH; Alshingetti N; Alomar SY; Alnaami AM; Amer OE; Hussain SD; Al-Daghri NM
Nutrients; 2021 Jun; 13(7):. PubMed ID: 34202578
[TBL] [Abstract][Full Text] [Related]
11. Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial.
Murai IH; Fernandes AL; Sales LP; Pinto AJ; Goessler KF; Duran CSC; Silva CBR; Franco AS; Macedo MB; Dalmolin HHH; Baggio J; Balbi GGM; Reis BZ; Antonangelo L; Caparbo VF; Gualano B; Pereira RMR
JAMA; 2021 Mar; 325(11):1053-1060. PubMed ID: 33595634
[TBL] [Abstract][Full Text] [Related]
12. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
13. Impact of Serum 25(OH) Vitamin D Level on Mortality in Patients with COVID-19 in Turkey.
Karahan S; Katkat F
J Nutr Health Aging; 2021; 25(2):189-196. PubMed ID: 33491033
[TBL] [Abstract][Full Text] [Related]
14. High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial (CARED-TRIAL).
Mariani J; Tajer C; Antonietti L; Inserra F; Ferder L; Manucha W
Trials; 2021 Feb; 22(1):111. PubMed ID: 33522946
[TBL] [Abstract][Full Text] [Related]
15. Severe vitamin D deficiency is not related to SARS-CoV-2 infection but may increase mortality risk in hospitalized adults: a retrospective case-control study in an Arab Gulf country.
Alguwaihes AM; Sabico S; Hasanato R; Al-Sofiani ME; Megdad M; Albader SS; Alsari MH; Alelayan A; Alyusuf EY; Alzahrani SH; Al-Daghri NM; Jammah AA
Aging Clin Exp Res; 2021 May; 33(5):1415-1422. PubMed ID: 33788172
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D Deficiency Is Associated With Higher Hospitalization Risk From COVID-19: A Retrospective Case-control Study.
Jude EB; Ling SF; Allcock R; Yeap BXY; Pappachan JM
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4708-e4715. PubMed ID: 34139758
[TBL] [Abstract][Full Text] [Related]
17. Treatment With 25-Hydroxyvitamin D
Maghbooli Z; Sahraian MA; Jamalimoghadamsiahkali S; Asadi A; Zarei A; Zendehdel A; Varzandi T; Mohammadnabi S; Alijani N; Karimi M; Shirvani A; Holick MF
Endocr Pract; 2021 Dec; 27(12):1242-1251. PubMed ID: 34653608
[TBL] [Abstract][Full Text] [Related]
18. Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness.
Dror AA; Morozov N; Daoud A; Namir Y; Yakir O; Shachar Y; Lifshitz M; Segal E; Fisher L; Mizrachi M; Eisenbach N; Rayan D; Gruber M; Bashkin A; Kaykov E; Barhoum M; Edelstein M; Sela E
PLoS One; 2022; 17(2):e0263069. PubMed ID: 35113901
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D Intake May Reduce SARS-CoV-2 Infection Morbidity in Health Care Workers.
Karonova TL; Chernikova AT; Golovatyuk KA; Bykova ES; Grant WB; Kalinina OV; Grineva EN; Shlyakhto EV
Nutrients; 2022 Jan; 14(3):. PubMed ID: 35276863
[TBL] [Abstract][Full Text] [Related]
20. A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D-a randomised multicentre international clinical trial.
Cannata-Andía JB; Díaz-Sottolano A; Fernández P; Palomo-Antequera C; Herrero-Puente P; Mouzo R; Carrillo-López N; Panizo S; Ibañez GH; Cusumano CA; Ballarino C; Sánchez-Polo V; Pefaur-Penna J; Maderuelo-Riesco I; Calviño-Varela J; Gómez MD; Gómez-Alonso C; Cunningham J; Naves-Díaz M; Douthat W; Fernández-Martín JL;
BMC Med; 2022 Feb; 20(1):83. PubMed ID: 35177066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
